677 related articles for article (PubMed ID: 17324742)
1. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
3. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
4. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB
Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
[TBL] [Abstract][Full Text] [Related]
7. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
8. Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
Bech JN; Starklint J; Bentzen H; Nyvad O; Pedersen EB
J Card Fail; 2013 Nov; 19(11):776-85. PubMed ID: 24263123
[TBL] [Abstract][Full Text] [Related]
9. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated natriuresis during clamping of systemic NO supply in healthy young men.
Simonsen JA; Rasmussen MS; Vach W; Høilund-Carlsen PF; Bie P
Clin Sci (Lond); 2012 Jan; 122(2):63-73. PubMed ID: 21749320
[TBL] [Abstract][Full Text] [Related]
11. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
12. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
14. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
Millar CG; Thiemermann C
Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
17. Normal renal tubular response to changes of sodium intake in hypertensive man.
Bruun NE; Skøtt P; Damkjaer Nielsen M; Rasmussen S; Schütten HJ; Leth A; Pedersen EB; Giese J
J Hypertens; 1990 Mar; 8(3):219-27. PubMed ID: 2159502
[TBL] [Abstract][Full Text] [Related]
18. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs.
Golbaekdal K; Nielsen CB; Djurhuus JC; Pedersen EB
Transplantation; 1994 Dec; 58(11):1153-7. PubMed ID: 7992354
[TBL] [Abstract][Full Text] [Related]
19. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
20. Assessment of endothelial function of the renal vasculature in human subjects.
Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
